Sfoglia per Autore
A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers.
2024-01-01 Magrassi, L; Pinton, G; Luzzi, S; Comincini, S; Scravaglieri, A; Gigliotti, V; Bernardoni, Bl; D'Agostino, I; Juretich, F; La Motta, C; Garavaglia, S.
EZH2-Mediated H3K27 Trimethylation in the Liver of Mice Is an Early Epigenetic Event Induced by High-Fat Diet Exposure
2024-01-01 Pinton, G.; Perucca, M.; Gigliotti, V.; Mantovani, E.; Clemente, N.; Malecka, J.; Chrostek, G.; Dematteis, G.; Lim, D.; Moro, L.; Chiazza, F.
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment
2023-01-01 Boumya, Sara; Fallarini, Silvia; Siragusa, Sonia; Petrarolo, Giovanni; Aprile, Silvio; Audrito, Valentina; La Motta, Concettina; Garavaglia, Silvia; Moro, Laura; Pinton, Giulia
Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma
2023-01-01 Al Khatib, M. H. D. O.; Pinton, G.; Moro, L.; Porta, C.
Melanoma Cells Inhibit iNKT Cell Functions via PGE2 and IDO1
2023-01-01 Torre, E.; Pinton, G.; Lombardi, G.; Fallarini, S.
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment
2022-01-01 Sculco, M.; La Vecchia, M.; Aspesi, A.; Pinton, G.; Clavenna, M. G.; Casalone, E.; Allione, A.; Grosso, F.; Libener, R.; Muzio, A.; Rena, O.; Baietto, G.; Parini, S.; Boldorini, R.; Giachino, D.; Papotti, M.; Scagliotti, G. V.; Migliore, E.; Mirabelli, D.; Moro, L.; Magnani, C.; Ferrante, D.; Matullo, G.; Dianzani, I.
The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake
2022-01-01 Gabano, E.; Zanellato, I.; Pinton, G.; Moro, L.; Ravera, M.; Osella, D.
Epigenetic Insights on PARP-1 Activity in Cancer Therapy
2022-01-01 Pinton, Giulia; Boumya, Sara; Rosa Ciriolo, Maria; Ciccarone, Fabio
CDKN2A determines mesothelioma cell fate to EZH2 inhibition
2021-01-01 Pinton, Giulia; Wang, Zhuo; Balzano, Cecilia; Missaglia, Sara; Tavian, Daniela; Boldorini, Renzo; A Fennell, Dean; Griffin, Martin; Moro, Laura
Inhibition of the histone methyltransferase ezh2 enhances protumor monocyte recruitment in human mesothelioma spheroids
2021-01-01 Mola, S.; Pinton, G.; Erreni, M.; Corazzari, M.; Andrea, M. D.; Grolla, A. A.; Martini, V.; Moro, L.; Porta, C.
Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review
2021-01-01 Pinton, Giulia; Manzotti, Beatrice; Balzano, Cecilia; Moro, Laura
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines
2021-01-01 Gabano, E.; Pinton, G.; Balzano, C.; Boumya, S.; Osella, D.; Moro, L.; Ravera, M.
Specific low-frequency electromagnetic fields induce expression of active KDM6B associated with functional changes in U937 cells
2020-01-01 Pinton, G.; Ferraro, A.; Balma, M.; Moro, L.
Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition
2019-01-01 Ayinde, O.; Wang, Z.; Pinton, G.; Moro, L.; Griffin, M.
Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality
2018-01-01 Pinton, Giulia; Nilsson, Stefan; Moro, Laura
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia
2017-01-01 Zonca, Sara; Pinton, Giulia; Wang, Z; Soluri, Mf; Tavian, D; Griffin, M; Sblattero, D; Moro, Laura
Expression and therapeutic significance of estrogen receptor beta (ERβ) in malignant pleural mesothelioma
2017-01-01 Pinton, Giulia; Moro, Laura
Pharmaceutical combinations comprising estrogen receptor-beta agonists with platinum drugs or paclitaxel for treating ovarian cancer
2016-01-01 Nilsson, Stefan; Moro, Laura; Pinton, Giulia
SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells.
2016-01-01 Pinton, Giulia; Zonca, Sara; Manente, Arcangela Gabriella; Cavaletto, Maria; Borroni, E; Daga, A; Jithesh, Pv; Fennell, D; Nilsson, S; Moro, Laura
KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma
2016-01-01 Manente, Arcangela Gabriella; Pinton, Giulia; Zonca, Sara; Tavian, Daniela; Habib, Tanwir; Jithesh, Puthen V; Fennell, Dean; Nilsson, Stefan; Moro, Laura
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers. | 1-gen-2024 | Magrassi, L; Pinton, G; Luzzi, S; Comincini, S; Scravaglieri, A; Gigliotti, V; Bernardoni, Bl; D'Agostino, I; Juretich, F; La Motta, C; Garavaglia, S. | |
EZH2-Mediated H3K27 Trimethylation in the Liver of Mice Is an Early Epigenetic Event Induced by High-Fat Diet Exposure | 1-gen-2024 | Pinton, G.; Perucca, M.; Gigliotti, V.; Mantovani, E.; Clemente, N.; Malecka, J.; Chrostek, G.; Dematteis, G.; Lim, D.; Moro, L.; Chiazza, F. | |
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment | 1-gen-2023 | Boumya, Sara; Fallarini, Silvia; Siragusa, Sonia; Petrarolo, Giovanni; Aprile, Silvio; Audrito, Valentina; La Motta, Concettina; Garavaglia, Silvia; Moro, Laura; Pinton, Giulia | |
Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma | 1-gen-2023 | Al Khatib, M. H. D. O.; Pinton, G.; Moro, L.; Porta, C. | |
Melanoma Cells Inhibit iNKT Cell Functions via PGE2 and IDO1 | 1-gen-2023 | Torre, E.; Pinton, G.; Lombardi, G.; Fallarini, S. | |
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment | 1-gen-2022 | Sculco, M.; La Vecchia, M.; Aspesi, A.; Pinton, G.; Clavenna, M. G.; Casalone, E.; Allione, A.; Grosso, F.; Libener, R.; Muzio, A.; Rena, O.; Baietto, G.; Parini, S.; Boldorini, R.; Giachino, D.; Papotti, M.; Scagliotti, G. V.; Migliore, E.; Mirabelli, D.; Moro, L.; Magnani, C.; Ferrante, D.; Matullo, G.; Dianzani, I. | |
The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake | 1-gen-2022 | Gabano, E.; Zanellato, I.; Pinton, G.; Moro, L.; Ravera, M.; Osella, D. | |
Epigenetic Insights on PARP-1 Activity in Cancer Therapy | 1-gen-2022 | Pinton, Giulia; Boumya, Sara; Rosa Ciriolo, Maria; Ciccarone, Fabio | |
CDKN2A determines mesothelioma cell fate to EZH2 inhibition | 1-gen-2021 | Pinton, Giulia; Wang, Zhuo; Balzano, Cecilia; Missaglia, Sara; Tavian, Daniela; Boldorini, Renzo; A Fennell, Dean; Griffin, Martin; Moro, Laura | |
Inhibition of the histone methyltransferase ezh2 enhances protumor monocyte recruitment in human mesothelioma spheroids | 1-gen-2021 | Mola, S.; Pinton, G.; Erreni, M.; Corazzari, M.; Andrea, M. D.; Grolla, A. A.; Martini, V.; Moro, L.; Porta, C. | |
Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review | 1-gen-2021 | Pinton, Giulia; Manzotti, Beatrice; Balzano, Cecilia; Moro, Laura | |
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines | 1-gen-2021 | Gabano, E.; Pinton, G.; Balzano, C.; Boumya, S.; Osella, D.; Moro, L.; Ravera, M. | |
Specific low-frequency electromagnetic fields induce expression of active KDM6B associated with functional changes in U937 cells | 1-gen-2020 | Pinton, G.; Ferraro, A.; Balma, M.; Moro, L. | |
Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition | 1-gen-2019 | Ayinde, O.; Wang, Z.; Pinton, G.; Moro, L.; Griffin, M. | |
Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality | 1-gen-2018 | Pinton, Giulia; Nilsson, Stefan; Moro, Laura | |
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia | 1-gen-2017 | Zonca, Sara; Pinton, Giulia; Wang, Z; Soluri, Mf; Tavian, D; Griffin, M; Sblattero, D; Moro, Laura | |
Expression and therapeutic significance of estrogen receptor beta (ERβ) in malignant pleural mesothelioma | 1-gen-2017 | Pinton, Giulia; Moro, Laura | |
Pharmaceutical combinations comprising estrogen receptor-beta agonists with platinum drugs or paclitaxel for treating ovarian cancer | 1-gen-2016 | Nilsson, Stefan; Moro, Laura; Pinton, Giulia | |
SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells. | 1-gen-2016 | Pinton, Giulia; Zonca, Sara; Manente, Arcangela Gabriella; Cavaletto, Maria; Borroni, E; Daga, A; Jithesh, Pv; Fennell, D; Nilsson, S; Moro, Laura | |
KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma | 1-gen-2016 | Manente, Arcangela Gabriella; Pinton, Giulia; Zonca, Sara; Tavian, Daniela; Habib, Tanwir; Jithesh, Puthen V; Fennell, Dean; Nilsson, Stefan; Moro, Laura |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile